| Name | KRAS G12C inhibitor 34 |
|---|---|
| Synonyms | 6H-Pyrazino[2,1-c][1,4]benzoxazin-6-one, 10-chloro-1,2,3,4,12,12a-hexahydro-7-[[2-(1-methylethyl)phenyl]amino]-9-(5-methyl-1H-indazol-4-yl)-2-(1-oxo-2-propen-1-yl)-, (12) |
| Description | KRAS G12C inhibitor 34 is a KRAS G12C inhibitor extracted from patent WO2021239058A1, compound Z1. KRAS G12C inhibitor 34 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C32H32ClN5O3 |
|---|---|
| Molecular Weight | 570.08 |